American College of Medical Genetics, Bethesda, Maryland 20814, USA.
Genet Med. 2010 Dec;12(12 Suppl):S269-72. doi: 10.1097/GIM.0b013e3181fea489.
The outcomes of a meeting that focused on the role of the residual dried blood spots from newborn screening for uses in the improvement of newborn screening are reported. Discussions of policy development, such as this one, begin by identifying the problem to be solved; in this case, it is achieving common ground to develop consistent policies for the use of residual dried blood spots, such that their benefits to the public's health and the health of children are amplified, and harms are minimized. Similarly, the issue must be considered contextually. The example of newborn screening for phenylketonuria was used to highlight the issues in the context of the condition with the longest history in newborn screening. Principles and recommendations for the use of the residual dried blood spot were developed.
会议重点讨论了新生儿筛查中遗留的干血斑在改善新生儿筛查方面的作用，现将会议结果报告如下。此类政策制定的讨论首先要确定需要解决的问题；在这种情况下，就是要达成共识，制定一致的政策来使用遗留的干血斑，以扩大其对公众健康和儿童健康的益处，同时将危害降到最低。同样，这个问题必须从上下文中考虑。以新生儿筛查苯丙酮尿症为例，突出了在新生儿筛查历史最长的情况下的相关问题。还制定了使用遗留的干血斑的原则和建议。
